Qiagen N.V. Logo

Qiagen N.V.

Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.

QIA | F

Overview

Corporate Details

ISIN(s):
DE000A286LP0 (+4 more)
LEI:
54930036WK3GMCN17Z57
Country:
Netherlands
Address:
HULSTERWEG 82, 5912 PL VENLO
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Qiagen N.V. is a leading global provider of integrated "Sample to Insight" solutions designed to enable customers to gain valuable molecular insights from biological samples. The company's comprehensive portfolio covers the entire molecular testing workflow, from sample preparation technologies that isolate DNA, RNA, and proteins, to assay technologies and automated instrumentation for analysis. Qiagen also provides bioinformatics software to interpret the resulting data. Its products are utilized by a diverse customer base across molecular diagnostics, academic research, pharmaceutical development, and applied testing, facilitating advancements in life sciences and clinical healthcare.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 11:25
Interim Report
Qiagen N.V., Halfjaarlijkse financiële verslaggeving
English 268.3 KB
2025-08-28 07:57
Capital/Financing Update
QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled converti…
English 18.4 KB
2025-08-22 00:00
Foreign Filer Report
Half-yearly financial report 2025
English 428.1 KB
2025-05-13 00:00
Foreign Filer Report
Q1 statement / Q1 financial report 2025
English 693.8 KB
2025-05-07 14:35
Notice of Dividend Amount
QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for sharehold…
English 6.8 KB
2025-04-28 16:33
Annual Report (ESEF)
Qiagen N.V., Jaarlijkse financiële verslaggeving
English 23.4 MB
2025-04-06 18:20
Earnings Release
QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates fu…
English 7.2 KB
2025-03-31 00:00
Annual Report
Annual financial report 2024
English 6.2 MB
2025-02-06 06:31
Earnings Release
QIAGEN delivers solid Q4 2024 growth ahead of outlook
English 478.9 KB
2025-01-13 18:55
Transaction in Own Shares
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders throug…
English 7.7 KB
2025-01-12 18:55
Share Issue/Capital Change
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders throug…
English 7.7 KB
2024-11-07 07:30
Earnings Release
QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024…
English 421.6 KB
2024-09-03 09:01
Capital/Financing Update
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
English 56.8 KB
2024-09-03 09:01
Capital/Financing Update
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
English 44.5 KB
2024-08-16 15:34
Interim Report
English 565.7 KB

Automate Your Workflow. Get a real-time feed of all Qiagen N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Qiagen N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-04-17 S. Rusckowski Non-Executive member Other 26 N/A
2023-03-14 E.R. Mardis Non-Executive member Sell 4,739 218,422.41 USD
2023-02-28 E. Pisa Non-Executive member Other 7,917 N/A
2023-02-21 R. Sackers Non-Executive member Other 51,500 N/A
2022-12-01 R. Sackers Non-Executive member Sell 30,000 1,500,000.00 USD
2022-10-31 M. Colpan Non-Executive member Other 457 N/A
2022-06-08 R. Sackers Non-Executive member Sell 32,398 1,522,706.00 USD
2022-03-31 R. Sackers Non-Executive member Other 72,944 N/A
2022-03-15 R. Sackers Non-Executive member Other 7,606 N/A
2022-03-14 E.R. Mardis Non-Executive member Sell 5,003 228,330.77 USD

Peer Companies

Company Country Ticker View
RUA LIFE SCIENCES PLC Logo
Develops and licenses implantable polymer tech and provides contract manufacturing services.
United Kingdom RUA
S2Medical AB Logo
Develops advanced wound healing and infection control solutions for burns and chronic wounds.
Sweden S2M
Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France ALSAF
Safilo Group Logo
Designs, manufactures, and distributes sunglasses, optical frames, and sports eyewear globally.
Italy SFL
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany 1SXP
Scope Fluidics S.A. Logo
Biotech venture builder creating microfluidic diagnostic systems for healthcare.
Poland SCP
Sedana Medical Logo
Develops inhaled sedation technology for mechanically ventilated patients in intensive care.
Sweden SEDANA
SEED CO.,LTD. Logo
Japanese manufacturer of high-quality contact lenses and advanced eye care products for global markets.
Japan 7743

Talk to a Data Expert

Have a question? We'll get back to you promptly.